Cargando…

Cost-effectiveness analysis of a universal mass vaccination program with a PHiD-CV 2+1 schedule in Malaysia

BACKGROUND: Currently, two pediatric pneumococcal conjugate vaccines are available in the private market of Malaysia—13-valent pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide and non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV). This study aimed to eva...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xiao Jun, Saha, Ashwini, Zhang, Xu-Hao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568314/ https://www.ncbi.nlm.nih.gov/pubmed/28852326 http://dx.doi.org/10.1186/s12962-017-0079-2

Ejemplares similares

Cost-effectiveness analysis of infant pneumococcal vaccination with PHiD-CV in Korea
por: Zhang, Xu-Hao, et al.
Publicado: (2017)

A cost-effectiveness analysis of PHiD-CV compared to PCV13 in a national immunization program setting in Tunisia
por: Lagoubi, Youness, et al.
Publicado: (2022)

Overall effectiveness of pneumococcal conjugate vaccines: An economic analysis of PHiD-CV and PCV-13 in the immunization of infants in Italy
por: Castiglia, Paolo, et al.
Publicado: (2017)

Cost-effectiveness analysis of routine pneumococcal vaccination in the UK: a comparison of the PHiD-CV vaccine and the PCV-13 vaccine using a Markov model
por: Delgleize, Emmanuelle, et al.
Publicado: (2016)

Exploring the evidence behind the comparable impact of the pneumococcal conjugate vaccines PHiD-CV and PCV13 on overall pneumococcal disease
por: Izurieta, Patricia, et al.
Publicado: (2021)

A Cost-Effectiveness Analysis of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) for Universal Mass Vaccination Implementation in New Zealand
por: Varghese, Lijoy, et al.
Publicado: (2018)

Effects of Vaccination with 10-Valent Pneumococcal Non-Typeable Haemophilus influenza Protein D Conjugate Vaccine (PHiD-CV) on the Nasopharyngeal Microbiome of Kenyan Toddlers
por: Feazel, Leah M., et al.
Publicado: (2015)

A randomised trial to evaluate the immunogenicity, reactogenicity, and safety of the 10-valent pneumococcal non-typeable Haemophilus influenzaeprotein D conjugate vaccine (PHiD-CV) co-administered with routine childhood vaccines in Singapore and Malaysia
por: Lim, Fong Seng, et al.
Publicado: (2014)

A 6-year safety surveillance of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in South Korea
por: Lee, Soon Min, et al.
Publicado: (2018)

Primary vaccination with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in infants in Mali and Nigeria: a randomized controlled trial
por: Dicko, Alassane, et al.
Publicado: (2011)

Estimated public health impact of human rotavirus vaccine (HRV) and pneumococcal polysaccharide protein D-conjugate vaccine (PHiD-CV) on child morbidity and mortality in Gavi-supported countries
por: Marijam, Alen, et al.
Publicado: (2022)

Efficacy of Pneumococcal Nontypable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) in Young Latin American Children: A Double-Blind Randomized Controlled Trial
por: Tregnaghi, Miguel W., et al.
Publicado: (2014)

Safety, reactogenicity and immunogenicity of a booster dose of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Malian children
por: Dicko, Alassane, et al.
Publicado: (2013)

10‐valent pneumococcal non‐typeable Haemophilus influenzae protein‐D conjugate vaccine (PHiD‐CV) induces memory B cell responses in healthy Kenyan toddlers
por: Muema, D. M., et al.
Publicado: (2015)

Correction: Efficacy of Pneumococcal Nontypable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) in Young Latin American Children: A Double-Blind Randomized Controlled Trial
por: Tregnaghi, Miguel W., et al.
Publicado: (2015)

Pneumonia hospitalizations and mortality in children 3 – 24-month-old in Nigeria from 2013 to 2020: Impact of pneumococcal conjugate vaccine ten valent (PHiD-CV-10)
por: Iliya, Jalo, et al.
Publicado: (2023)

Immunogenicity and safety of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) co-administered with DTPa vaccine in Japanese children: A randomized, controlled study
por: Iwata, Satoshi, et al.
Publicado: (2015)

Effectiveness of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D–Conjugated Vaccine (PHiD-CV) Against Carriage and Acute Otitis Media—A Double-Blind Randomized Clinical Trial in Finland
por: Vesikari, Timo, et al.
Publicado: (2016)

Safety and immunogenicity of 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Nigerian children: Booster dose and 2-dose catch-up regimens in the second year of life
por: Odusanya, Olumuyiwa O, et al.
Publicado: (2014)

Serotype changes and antimicrobial nonsusceptibility rates of invasive and non-invasive Streptococcus pneumoniae isolates after implementation of 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Bulgaria
por: Setchanova, Lena, et al.
Publicado: (2017)

phiD12-Like Livestock-Associated Prophages Are Associated With Novel Subpopulations of Streptococcus agalactiae Infecting Neonates
por: Renard, Adélaïde, et al.
Publicado: (2019)

Safety, reactogenicity and immunogenicity of 2-dose catch-up vaccination with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Malian children in the second year of life: Results from an open study
por: Dicko, Alassane, et al.
Publicado: (2015)

Effects of prophylactic ibuprofen and paracetamol administration on the immunogenicity and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugated vaccine (PHiD-CV) co-administered with DTPa-combined vaccines in children: An open-label, randomized, controlled, non-inferiority trial
por: Falup-Pecurariu, Oana, et al.
Publicado: (2016)

Scheduling of $\Phi_{+ -}$ experiment
por: CERN. Geneva, et al.
Publicado: (1969)

Summary of WG7 at CKM 2018: "Mixing and $CP$ violation in the $D$ system: $x_D$, $y_D$, $|q/p|_D$, $\phi_D$, and direct $CP$ violation in $D$ decays"
por: Bhardwaj, Vishal, et al.
Publicado: (2019)

10-Valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine (PHiD-CV10) versus 13-valent pneumococcal conjugate vaccine (PCV13) as a booster dose to broaden and strengthen protection from otitis media (PREVIX_BOOST) in Australian Aboriginal children: study protocol for a randomised controlled trial
por: Oguoma, Victor M, et al.
Publicado: (2020)

Memorandum: Scheduling of $\Phi_{\eta_{+-}}$ experiment
por: Steinberger, J
Publicado: (1969)

Memorandum: Scheduling of $\Phi_{\eta{+-}}$ experiment (S93)
por: CERN. Geneva, et al.
Publicado: (1969)

Cost-Effectiveness of Pertussis Vaccination Schedule in Israel
por: Langsam, Dean, et al.
Publicado: (2021)

A high statistics study of the phi.phi mass spectrum
por: Booth, P S L, et al.
Publicado: (1985)

On the mass COVID-19 vaccination scheduling problem
por: Zhang, Chuang, et al.
Publicado: (2022)

34. Impact of Universal Mass Vaccination Programs of Children Against Hepatitis a with 2-dose and 1-dose Schedules: A Systematic Literature Review
por: Andani, Anar, et al.
Publicado: (2020)

Integration of Schwinger equation for ($\phi*\phi$)$_{d}^{2}$ theory
por: Rochev, V E
Publicado: (1993)

Program Schedule
Publicado: (1983)

DA$\phi$NE and the experimental program
por: Bianco, S
Publicado: (1995)

The DA$\Phi$NE physics program
por: Lee-Franzini, Juliet
Publicado: (1996)

Cost effectiveness of quadrivalent influenza vaccines in the elderly population of Malaysia
por: Aljunid, Syed Mohamed, et al.
Publicado: (2023)

A measurement of B(D$_{s}^{+}$ --> .phi $\ell$sup(+)$\nu$)/B(D$_{s}^{+}$ --> $\phi\pi^{+}$)
por: Butler, F, et al.
Publicado: (1994)

The cost of radiological procedures at Universiti Kebangsaan Malaysia Medical Centre: applying activity based costing methodology
por: Ibrahim, Roszita, et al.
Publicado: (2014)

Schedule, cost, and profit control with PERT: a comprehensive guide for program management
por: Miller, Robert Wallace
Publicado: (1963)

Cannot write session to /tmp/vufind_sessions/sess_vot1p80809aq2hqflahqk455e6